[1]
Margolis, S. 2013. Destined for Failure? An Analysis of the Biologics Price Competition and Innovation Act of 2009. Columbia Business Law Review. 2013, 1 (May 2013), 209–241. DOI:https://doi.org/10.7916/cblr.v2013i1.1794.